SASSO, EMANUELE
 Distribuzione geografica
Continente #
AS - Asia 1.588
EU - Europa 1.461
NA - Nord America 1.419
SA - Sud America 154
Continente sconosciuto - Info sul continente non disponibili 93
AF - Africa 39
OC - Oceania 1
Totale 4.755
Nazione #
US - Stati Uniti d'America 1.345
SG - Singapore 605
IT - Italia 577
RU - Federazione Russa 495
VN - Vietnam 350
CN - Cina 298
BR - Brasile 121
HK - Hong Kong 98
DE - Germania 77
GB - Regno Unito 74
FR - Francia 60
NL - Olanda 59
BD - Bangladesh 54
IN - India 51
FI - Finlandia 33
JP - Giappone 33
CA - Canada 32
KR - Corea 23
MX - Messico 17
SE - Svezia 16
AR - Argentina 15
CI - Costa d'Avorio 13
ZA - Sudafrica 13
ES - Italia 11
IE - Irlanda 11
PH - Filippine 11
PL - Polonia 10
AT - Austria 8
IQ - Iraq 8
TH - Thailandia 8
CR - Costa Rica 7
EC - Ecuador 7
LT - Lituania 7
TR - Turchia 7
UA - Ucraina 7
AE - Emirati Arabi Uniti 5
BE - Belgio 5
JM - Giamaica 5
PY - Paraguay 5
ID - Indonesia 4
JO - Giordania 4
PK - Pakistan 4
RO - Romania 4
UZ - Uzbekistan 4
CL - Cile 3
GT - Guatemala 3
MY - Malesia 3
OM - Oman 3
AL - Albania 2
BW - Botswana 2
CO - Colombia 2
CZ - Repubblica Ceca 2
EG - Egitto 2
ET - Etiopia 2
GE - Georgia 2
GP - Guadalupe 2
HN - Honduras 2
LA - Repubblica Popolare Democratica del Laos 2
MA - Marocco 2
NI - Nicaragua 2
SA - Arabia Saudita 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
DZ - Algeria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
LY - Libia 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TC - Turks e Caicos 1
TN - Tunisia 1
VE - Venezuela 1
Totale 4.662
Città #
Singapore 298
San Jose 249
Naples 239
Ashburn 150
Moscow 119
Chandler 106
Hong Kong 96
Beijing 90
Ho Chi Minh City 89
Hanoi 73
Santa Clara 72
Hefei 52
Amsterdam 51
Council Bluffs 51
Los Angeles 45
The Dalles 45
Napoli 35
Lauterbourg 33
Tokyo 27
Munich 26
New York 25
Milan 22
Millbury 22
Dallas 20
Rome 17
Pune 16
Frankfurt am Main 15
San Paolo Bel Sito 15
Seoul 15
Lawrence 14
Redondo Beach 14
Denver 13
São Paulo 13
Buffalo 12
Chicago 12
Da Nang 12
Des Moines 12
Haiphong 12
Helsinki 12
Biên Hòa 11
Boston 11
Orem 11
Seattle 11
Toronto 11
Nanjing 10
Brooklyn 9
Florence 9
Kochi 9
Lappeenranta 9
London 9
Düsseldorf 8
Falkenstein 8
Houston 8
Warsaw 8
Hải Dương 7
Johannesburg 7
Marano 7
San José 7
Stockholm 7
Washington 7
Wilmington 7
Chennai 6
Columbus 6
Formia 6
Hangzhou 6
Mexico City 6
Nuremberg 6
Ottawa 6
Princeton 6
Tianjin 6
Turku 6
Atlanta 5
Belo Horizonte 5
Capaccio 5
Hyderabad 5
Montreal 5
Nha Trang 5
Phoenix 5
Poplar 5
Portsmouth 5
San Francisco 5
Amman 4
Bologna 4
Brussels 4
Ercolano 4
Jiaxing 4
Kingston 4
Marano di Napoli 4
Memphis 4
New Delhi 4
Salerno 4
Shanghai 4
Thái Bình 4
Trentola-Ducenta 4
Acerra 3
Afragola 3
Arezzo 3
Avellino 3
Baghdad 3
Bắc Giang 3
Totale 2.610
Nome #
Revealing membrane alteration in cellsoverexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering 208
Generation of a novel mesothelin-targeted oncolytic herpes virus and implemented strategies for manufacturing 196
Integrating system biology and intratumor gene therapy by trans-complementing the appropriate co-stimulatory molecule as payload in oncolytic herpes virus 191
Integrity of the antiviral STING-mediated DNA sensing in tumor cells is required to sustain the immunotherapeutic efficacy of herpes simplex oncolytic virus 183
A Novel Human Neutralizing mAb Recognizes Delta, Gamma and Omicron Variants of SARS-CoV-2 and Can Be Used in Combination with Sotrovimab 181
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 175
One-Step Recovery of scFv Clones from High-Throughput Sequencing-Based Screening of Phage Display Libraries Challenged to Cells Expressing Native Claudin-1 154
Binding of Carbonic Anhydrase IX to 45S rDNA Genes Is Prevented by Exportin-1 in Hypoxic Cells 152
Rapid Affinity Maturation of Novel Anti-PD-L1 Antibodies by a Fast Drop of the Antigen Concentration and FACS Selection of Yeast Libraries 152
Generation of a retargeted oncolytic herpes virus encoding adenosine deaminase for tumor adenosine clearance 152
Massive parallel screening of phage libraries for the generation of repertoires of human immunomodulatory monoclonal antibodies. 149
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 148
Novel human anti-Claudin 1 monoclonal antibodies inhibit HCV infection and may synergize with anti-SRB1 mAb. 147
A long non-coding SINEUP RNA boosts semi-stable production of fully human monoclonal antibodies in HEK293E cells 147
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 143
Prime and pull of Tcell responses against cancer-exogenous antigens is effective against CPI-resistant tumors 140
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 138
New Insights on the Role of Anti-PD-L1 and Anti-CTLA-4 mAbs on Different Lymphocytes Subpopulations in TNBC 136
High-Throughput Monoclonal Antibody Discovery from Phage Libraries: Challenging the Current Preclinical Pipeline to Keep the Pace with the Increasing mAb Demand 136
Disclosing the Interaction of Carbonic Anhydrase IX with Cullin-Associated NEDD8-Dissociated Protein 1 by Molecular Modeling and Integrated Binding Measurements 135
New viral vectors for infectious diseases and cancer 135
Peptide nucleic acid-mediated circularization of target RNA as tool to inhibit translation 134
Retargeted and Multi-cytokine-Armed Herpes Virus Is a Potent Cancer Endovaccine for Local and Systemic Anti-tumor Treatment 134
Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays 129
Carbonic anhydrase IX subcellular localization in normoxic and hypoxic SH-SY5Y neuroblastoma cells is assisted by its C-terminal protein interaction domain 128
Replicative conditioning of Herpes simplex type 1 virus by Survivin promoter, combined to ERBB2 retargeting, improves tumour cell-restricted oncolysis 126
Targeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosis 124
A functional analysis of the unclassified Pro2767Ser BRCA2 variant reveals its potential pathogenicity that acts by hampering DNA binding and homology-mediated DNA repair 123
Identification of a microRNA (miR-663a) induced by ER stress and its target gene PLOD3 by a combined microRNome and proteome approach 120
The common H232 STING allele shows impaired activities in DNA sensing, susceptibility to viral infection, and in monocyte cell function, while the HAQ variant possesses wild-type properties 108
Generation of novel human anti-OX-40 mAbs endowed with different biological properties as tools for cancer therapy 85
Recombineering-based Manufacturing of Engineered Viral Vectors for Research and Therapy 70
Adenovirus Encoded Adjuvant (AdEnA) anti-CTLA-4, a novel strategy to improve Adenovirus based vaccines against infectious diseases and cancer 44
Lipid self-assembling nanoparticles as a novel platform for mRNA-based vaccination 37
We ARE boosting translation: AU-rich elements for enhanced therapeutic mRNA translation 34
FKBP5 isoforms shape immune pathways related to tumor tolerance 31
Broadly cross-reactive mRNA COVID-19 vaccine encoding trimeric RBDs and NSP12 mitigates immune imprinting 17
Publisher Correction: Revealing membrane alteration in cells overexpressing CA IX and EGFR by Surface-Enhanced Raman Scattering (Scientific Reports, (2019), 9, 1, (1832), 10.1038/s41598-018-37997-3) 8
Editorial: Crosstalk in tumor microenvironments: shaping early drug and immunotherapy strategies 5
Totale 4.755
Categoria #
all - tutte 14.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022208 0 5 11 4 9 10 31 12 24 22 39 41
2022/2023274 22 16 5 22 34 35 1 20 44 50 23 2
2023/2024287 15 26 56 29 13 45 8 20 3 29 31 12
2024/20251.241 73 35 29 24 42 96 108 80 58 136 458 102
2025/20262.432 223 140 212 220 423 111 261 114 308 192 125 103
2026/2027144 52 92 0 0 0 0 0 0 0 0 0 0
Totale 4.755